Modeling the complex smoking exposure history in assessment of pan-cancer risk
en-GBde-DEes-ESfr-FR

Modeling the complex smoking exposure history in assessment of pan-cancer risk

19/11/2026 HEP Journals

Tobacco smoke carries more than seventy known carcinogens, and the damage it inflicts accumulates over decades. Epidemiology compresses that accumulation into pack-years, a quantity that multiplies cigarettes smoked per day by years of smoking and divides by twenty. Convenience of the measure conceals a structural problem: raising daily consumption while holding duration fixed necessarily raises the total dose, so a conventional log-linear model cannot separate what intensity does from what time does. Earlier attempts to prise the two apart leaned on case-control series, where smoking histories are reconstructed from memory years after diagnosis and are therefore vulnerable to recall bias. Prospective cohorts, which record exposure before disease appears, offer a firmer footing for asking whether a dose delivered quickly carries the same hazard as the identical dose delivered slowly.
Answers came from the UK Biobank. Of 502,505 participants, 491,062 with complete and internally consistent smoking records were retained. Twelve cancers identified by the US Centers for Disease Control and Prevention as causally linked to smoking were ascertained through linked national cancer registries, with person-time accrued from enrolment until diagnosis, death or the end of follow-up. Exposure was not entered as a single pack-year term. Instead, the analysts modelled ERR per pack-year and permitted smoking intensity to modify that slope, which makes low-intensity, long-duration histories directly comparable with high-intensity, short-duration histories at matched cumulative exposure. Time since cessation entered the same framework. Physical activity, diet quality and other lifestyle variables were then tested as modifiers of the exposure-response relationship, and the models were adjusted for age, sex, body mass index, alcohol use, education and other established risk factors.
Risk gradients refused to collapse onto a single pack-year scale. At equal cumulative exposure, participants who had smoked fewer cigarettes across more years and those who had smoked heavily across fewer years did not carry identical excess risk per pack-year, and the discrepancy was site-specific rather than uniform. Cessation shifted the slope: longer intervals since quitting were accompanied by lower ERR per pack-year for most of the twelve cancers, consistent with a gradual relaxation of carcinogenic drive once exposure stops. Lifestyle left its own signature. Regular physical activity and healthier dietary patterns were associated with smaller excess risks per pack-year than sedentary behaviour or poorer-quality diets, which suggests that the carcinogenic pressure of a given smoking history is partly modifiable even after the smoking itself has been quantified. The cohort also showed how much a single summary number can hide, since current smokers who developed cancer were overwhelmingly people who had smoked more than ten cigarettes a day, and former smokers who developed cancer were mostly people who had smoked for decades before quitting.
Consequences for practice follow directly. Screening programmes that admit participants on the basis of pack-years alone inevitably mis-rank people whose exposure was brief but intense against those whose exposure was light but lifelong, and the present analysis supplies a quantitative basis for correcting that ranking. Risk communication can likewise move beyond a single number: telling a patient that twenty pack-years accumulated over ten years differs materially from twenty pack-years accumulated over forty years is more informative than the aggregate alone. Prevention planning gains a similar lever, since the lifestyle modifiers identified here are actionable in populations that cannot undo their smoking history. Limitations remain. Smoking was self-reported at baseline rather than modelled as a time-varying exposure, follow-up in the cohort is still modest relative to the latency of solid tumours, and participants are healthier and older than the general population. Even so, the demonstration that intensity, duration and cessation history each alter excess risk per pack-year reframes a familiar metric and argues for rebuilding pan-cancer risk assessment around the full shape of exposure.
DOI
10.1007/s11684-026-1244-9
Fichiers joints
  • Fig1 Study overview and workflow.
19/11/2026 HEP Journals
Regions: Asia, China, Europe, United Kingdom, North America, United States
Keywords: Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Témoignages

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Nous travaillons en étroite collaboration avec...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement